chitosan has been researched along with sorbitan monostearate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdellatif, KRA; Abo El-Ela, FI; F, AG; Kharshoum, RM; Salem, HF | 1 |
| Battastini, AMO; Cé, R; Dallemole, DR; de Cristo Soares Alves, A; de Fraga Dias, A; Figueiró, F; Guterres, SS; Lavayen, V; Pohlmann, AR | 1 |
| Jain, A; Jain, SK; Panda, PK; Saraf, S; Tiwari, A; Verma, A | 1 |
3 other study(ies) available for chitosan and sorbitan monostearate
| Article | Year |
|---|---|
Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Cholesterol; Delayed-Action Preparations; Drug Liberation; Female; Gold; Hexoses; Hydrogen-Ion Concentration; Liposomes; Metal Nanoparticles; Mice; Tamoxifen; Tissue Distribution | 2018 |
Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Bevacizumab; Cell Line, Tumor; Cell Membrane Permeability; Chick Embryo; Chitosan; Chorioallantoic Membrane; Coordination Complexes; Dose-Response Relationship, Drug; Drug Compounding; Glioma; Gold; Hexoses; Humans; Lipids; Nanocapsules; Plant Lectins; Polysorbates; Soybean Proteins; Surface Properties; Vascular Endothelial Growth Factor A | 2020 |
Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.
Topics: Animals; Antifungal Agents; Cations; Chitosan; Drug Carriers; Drug Liberation; Eye Diseases; Hexoses; In Vitro Techniques; Liposomes; Mycoses; Particle Size; Rabbits; Surface-Active Agents | 2021 |